Literature DB >> 14716059

Synchronous primary carcinomas of the ampulla of Vater and ascending colon in a patient with multiple flat adenomas.

Marko Doko1, Mario Zovak, Elizabet Glavan, Mario Kopljar, Davor Tomas.   

Abstract

Multiple primary cancers occurring in the same patients have been reported to represent 1.8-3.9% of all cancers. The majority of all patients reported to have had a combination of simultaneous neoplastic changes in the ampulla of Vater and the colon showed familial adenomatous polyposis (FAP) syndrome. Variants of familial adenomatous polyposis coli are: attenuated adenomatous polyposis coli (AAPC, previously also known as flat adenoma syndrome) and multiple adenoma coli. AAPC is characterized clinically by many, but usually fewer than 100, colonic lesions that are characteristically slightly elevated and plaque-like, with a reddish surface and sometimes central depression. Genetically it represents an extremely rare variant of FAP. Another group of individuals, so-called multiple adenoma patients, have a phenotype similar to AAPC, but most have no demonstrable germ-line adenomatous polyposis coli mutation, as do patients with FAP or AAPC. However, there have been only a few reports that discussed concurrent neoplastic changes in the ampulla of Vater and colon in patients with multiple colonic flat adenomas, but without the florid phenotype of classical FAP. We present rare clinical course of a patient with multiple (more than 60) flat adenomas in the proximal colon and two primary cancers: of the ampulla of Vater and of the ascending colon. This patient and his family history did not show polyposis compatible with FAP or hereditary nonpolyposis colorectal cancer (HNPCC) syndrome.

Entities:  

Mesh:

Year:  2003        PMID: 14716059     DOI: 10.1385/IJGC:33:2-3:117

Source DB:  PubMed          Journal:  Int J Gastrointest Cancer        ISSN: 1537-3649


  31 in total

1.  Multiple cutaneous and subcutaneous lesions occurring simultaneously with hereditary polyposis and osteomatosis.

Authors:  E J GARDNER; R C RICHARDS
Journal:  Am J Hum Genet       Date:  1953-06       Impact factor: 11.025

2.  Frequency of germline hereditary non-polyposis colorectal cancer gene mutations in patients with multiple or early onset colorectal adenomas.

Authors:  N E Beck; I P Tomlinson; T F Homfray; I M Frayling; S V Hodgson; W F Bodmer
Journal:  Gut       Date:  1997-08       Impact factor: 23.059

3.  Gastric lesion of familial polyposis coli.

Authors:  J Utsunomiya; T Maki; T Iwama; Y Matsunaga; T Ichikawa
Journal:  Cancer       Date:  1974-09       Impact factor: 6.860

4.  Gastrointestinal polyposis and nonpolyposis syndromes.

Authors:  W S Samowitz; R W Burt; M Leppert
Journal:  N Engl J Med       Date:  1995-06-01       Impact factor: 91.245

5.  Gardner's syndrome and periampullary malignancy.

Authors:  J M Macdonald; W C Davis; H R Crago; A D Berk
Journal:  Am J Surg       Date:  1967-03       Impact factor: 2.565

6.  Whole-gene APC deletions cause classical familial adenomatous polyposis, but not attenuated polyposis or "multiple" colorectal adenomas.

Authors:  O M Sieber; H Lamlum; M D Crabtree; A J Rowan; E Barclay; L Lipton; S Hodgson; H J W Thomas; K Neale; R K S Phillips; S M Farrington; M G Dunlop; H J Mueller; M L Bisgaard; S Bulow; P Fidalgo; C Albuquerque; M I Scarano; W Bodmer; I P M Tomlinson; K Heinimann
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

7.  Familial polyposis coli and periampullary carcinoma.

Authors:  A H Qizilbash
Journal:  Can J Surg       Date:  1976-03       Impact factor: 2.089

8.  A prospective evaluation of the upper gastrointestinal tract and periampullary region in patients with Gardner syndrome.

Authors:  E Shemesh; L Bat
Journal:  Am J Gastroenterol       Date:  1985-11       Impact factor: 10.864

9.  Upper gastrointestinal tract polyps in familial adenomatosis coli.

Authors:  H Järvinen; M Nyberg; P Peltokallio
Journal:  Gut       Date:  1983-04       Impact factor: 23.059

10.  Flat early cancers of the large intestine.

Authors:  S Kuramoto; T Oohara
Journal:  Cancer       Date:  1989-08-15       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.